Noah Beerman

Noah Beerman is a seasoned biopharmaceutical executive currently serving as the CEO and Director of AI Proteins since April 2023, where the focus is on innovative protein therapeutics through AI-based design. Prior to this role, Beerman held various leadership positions including COO at Poxel SA from May 2015 to April 2023, and executive roles at Coronado Biosciences, RXi Pharmaceuticals Corp, and Indevus Pharmaceuticals. Beerman's extensive experience in business development and operations is complemented by an MBA in High Technology from Northeastern University and a Bachelor of Science in Molecular Genetics from the University of Rochester.